MS-HRM to Detect Serum DNA Methylation of Intrauterine Growth Retardation Children


Intrauterine growth retardation (IUGR) is also called fetal growth restriction (FGR), which is the major complications in obstetrics and one of the most important causation from high morbidity and mortality in perinatal. In this study, MS-HRM (Methylation-Sensitive High Resolution Melting Curve Analysis) was used to detect the methylation status of serum DNA. Gene of insulin-like growth factor binding protein 3 (IGFBP-3) was detected in this study. Results showed that the serum DNA methylation level of FGR fetus were lower than that of the control group; different methylation levels were also found between male and female fetus; and the methylation level was increased with the birth weight of the newborn. Our results showed that the IGFBP-3 gene methylation level of serum DNA of newborn could be semi-quantitative detected which guide the early prevention and treatment of IUGR. It also indicated that the methylation status of serum DNA can be conveniently identified and quantified by inspection of the melting curves.

Share and Cite:

Y. Du, Y. Zhou and Q. Wu, "MS-HRM to Detect Serum DNA Methylation of Intrauterine Growth Retardation Children," Engineering, Vol. 4 No. 10B, 2012, pp. 106-109. doi: 10.4236/eng.2012.410B027.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] W. E. Hoy, R. N. Douglas-Denton, M. D. Hughson, A. Cass, K. Johnson, and J. F. Bertram, "A stereological study of glomerular number and volume: preliminary findings in a multiracial study of kidneys at autopsy," Kidney Int Suppl, pp. S31-7, Feb 2003.
[2] K. A. Woods, C. Camacho-Hubner, D. Barter, A. J. Clark, and M. O. Savage, "Insulin-like growth factor I gene deletion causing intrauterine growth retardation and severe short stature," Acta Paediatr Suppl, vol. 423, pp. 39-45, Nov 1997.
[3] L. C. Giudice, F. de Zegher, S. E. Gargosky, B. A. Dsupin, L. de las Fuentes, R. A. Crystal, R. L. Hintz, and R. G. Rosenfeld, "Insulin-like growth factors and their binding proteins in the term and preterm human fetus and neonate with normal and extremes of intrauterine growth," J Clin Endocrinol Metab, vol. 80, pp. 1548-55, May 1995.
[4] A. M. Carter, M. J. Kingston, K. K. Han, D. M. Mazzuca, K. Nygard, and V. K. Han, "Altered expression of IGFs and IGF-binding proteins during intrauterine growth restriction in guinea pigs," J Endocrinol, vol. 184, pp. 179-89, Jan 2005.
[5] M. Faxen, J. Nasiell, A. Blanck, H. Nisell, and N. O. Lunell, "Altered mRNA expression pattern of placental epidermal growth factor receptor (EGFR) in pregnancies complicated by preeclampsia and/or intrauterine growth retardation," Am J Perinatol, vol. 15, pp. 9-13, Jan 1998.
[6] A. Lorente, W. Mueller, E. Urdangarin, P. Lazcoz, A. von Deimling, and J. S. Castresana, "Detection of methylation in promoter sequences by melting curve analysis-based semiquantitative real time PCR," BMC Cancer, vol. 8, p. 61, 2008.
[7] S. E. Cottrell, "Molecular diagnostic applications of DNA methylation technology," Clin Biochem, vol. 37, pp. 595-604, Jul 2004.
[8] C. T. Wittwer, G. H. Reed, C. N. Gundry, J. G. Vandersteen, and R. J. Pryor, "High-resolution genotyping by amplicon melting analysis using LCGreen," Clin Chem, vol. 49, pp. 853-60, Jun 2003.
[9] M. Frommer, L. E. McDonald, D. S. Millar, C. M. Collis, F. Watt, G. W. Grigg, P. L. Molloy, and C. L. Paul, "A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands," Proc Natl Acad Sci U S A, vol. 89, pp. 1827-31, Mar 1 1992.
[10] T. K. Wojdacz and A. Dobrovic, "Methylation-sensitive high resolution melting (MS-HRM): a new approach for sensitive and high-throughput assessment of methylation," Nucleic Acids Res, vol. 35, p. e41, 2007.
[11] H. Nakagawa, R. B. Chadwick, P. Peltomaki, C. Plass, Y. Nakamura, and A. de La Chapelle, "Loss of imprinting of the insulin-like growth factor II gene occurs by biallelic methylation in a core region of H19-associated CTCF-binding sites in colorectal cancer," Proc Natl Acad Sci U S A, vol. 98, pp. 591-6, Jan 16 2001.
[12] J. Worm, A. Aggerholm, and P. Guldberg, "In-tube DNA methylation profiling by fluorescence melting curve analysis," Clin Chem, vol. 47, pp. 1183-9, 2001.
[13] I. C. Beserra, M. G. Ribeiro, P. F. Collett-Solberg, M. Vaisman, and M. M. Guimaraes, "IGF-I and IGF Binding Protein-3 Generation Tests and Response to Growth Hormone in Children with Silver-Russell Syndrome," Int J Pediatr Endocrinol, vol. 2010, p. 546854.
[14] A. D. Riggs, "X inactivation, differentiation, and DNA methylation," Cytogenet Cell Genet, vol. 14, pp. 9-25, 1975.
[15] A. C. Filiberto, M. A. Maccani, D. Koestler, C. Wil-helm-Benartzi, M. Avissar-Whiting, C. E. Banister, L. A. Gagne, and C. J. Marsit, "Birthweight is associated with DNA promoter methylation of the glucocorticoid receptor in human placenta," Epigenetics, vol. 6, pp. 566-72, May.
[16] J. C. Ferreira, S. Choufani, D. Grafodatskaya, D. T. Butcher, C. Zhao, D. Chitayat, C. Shuman, J. Kingdom, S. Keating, and R. Weksberg, "WNT2 promoter methylation in human placenta is associated with low birthweight percentile in the neonate," Epigenetics, vol. 6, pp. 440-9, Apr.

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.